Role of Glucagon-like peptide-1 analogue versus Amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm

Venkat Sasidhar Renukuntla, Neesha Ramchandani, Jeniece Trast, Martin Cantwell, Rubina A. Heptulla

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Fingerprint Dive into the research topics of 'Role of Glucagon-like peptide-1 analogue versus Amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds

Engineering & Materials Science